Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A prospective, multi-centre therapeutic phase II parallel Randomised Control Trial. [electronic resource]
Producer: 20210804Description: 105999 p. digitalISSN:- 1559-2030
- Humans
- Male
- Ablation Techniques -- adverse effects
- Androgen Antagonists -- therapeutic use
- Anilides -- therapeutic use
- Brachytherapy -- adverse effects
- Costs and Cost Analysis
- Equivalence Trials as Topic
- Finasteride -- therapeutic use
- Neoadjuvant Therapy -- methods
- Neoplasm Recurrence, Local
- Nitriles -- therapeutic use
- Progression-Free Survival
- Prospective Studies
- Prostatectomy -- adverse effects
- Prostatic Neoplasms -- mortality
- Radiotherapy -- adverse effects
- Research Design
- Tosyl Compounds -- therapeutic use
- United Kingdom
- Randomized Controlled Trials as Topic
- Clinical Trials, Phase II as Topic
- Multicenter Studies as Topic
No physical items for this record
Publication Type: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.